In short: TRIUMPH-3 shows retatrutide can be used safely in a cardiovascular disease population without signal of harm, but the question of whether it actively reduces heart attacks and strokes remains open until TRIUMPH-Outcomes reports
This is why the shift in fat distribution caused by menopause is not just an aesthetic problem, but a clinical one
For instance, NMDAR antagonists and antioxidants show promise in mitigating the damage caused by dissociative anesthetics, whereas dopamine reuptake inhibitors and CBT may be more effective for psychostimulant-induced impairments
Retatrutide Dosing Guide Clinical titration guide with full PK rationale and reconstitution notes
10.1161/CIRCINTERVENTIONS.113.000642 43 SandooA.van ZantenJ
Lilly published these for the 12 mg arm only, with no 9 mg or placebo comparators, so they cannot be used to separate the drug's effect from the effect of the weight loss itself